Pulmonary pleomorphic carcinoma producing granulocyte-macrophage colony-stimulating factor: report of a case

Surg Today. 2012 Feb;42(3):288-91. doi: 10.1007/s00595-011-0043-2. Epub 2011 Nov 10.

Abstract

We report a case of lung cancer producing granulocyte-macrophage colony-stimulating factor (GM-CSF). The patient, a 55-year-old woman, was found to have leukocytosis (leukocytes 28.8 × 10(3)/mm3) with eosinophilia (eosinophils 24.5%) without any evidence of infection or allergy. The serum concentration of GM-CSF was elevated to 44 pg/ml (normal range <2.0 pg/ml), which might have induced the leukocytosis and eosinophilia. We performed left pneumonectomy and diagnosed a pleomorphic carcinoma with p-T2bN0M0, based on histological examination of the resected tumor. Immunohistochemical examination revealed GM-CSF. The serum level of GM-CSF decreased to within the normal range 8 days after surgery. At the time of writing, 16 months after the surgery, she was alive without disease. To our knowledge, this represents the first case report of a GM-CSF-producing tumor effectively treated by surgical resection.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism*
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / surgery
  • Middle Aged
  • Pneumonectomy

Substances

  • Biomarkers, Tumor
  • Granulocyte-Macrophage Colony-Stimulating Factor